{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?houseId=1&uin=192110&max-date=2018-11-16", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?houseId=1&uin=192110&max-date=2018-11-16", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?houseId=1&uin=192110&max-date=2018-11-16&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&houseId=1&uin=192110&max-date=2018-11-16", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?houseId=1&uin=192110&max-date=2018-11-16", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?houseId=1&uin=192110&max-date=2018-11-16", "items" : [{"_about" : "http://data.parliament.uk/resources/1008481", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1008481/answer", "answerText" : {"_value" : "

Following an announcement by NHS England on 14 November 2018, flash glucose monitoring systems will be made available on prescription for all patients with type 1 diabetes who meet National Health Service criteria from April 2019.<\/p>

<\/p>

No estimate has been made of the potential savings related to making flash glucose monitoring technology available to all patients with diabetes.<\/p>

<\/p>

A search of the Department\u2019s Ministerial correspondence database has identified 272 items of correspondence from members of the public received in 2018 about flash glucose monitoring. This figure represents correspondence received by the Department\u2019s Ministerial correspondence unit only. The Department has not been able to identify any correspondence specifically from charities.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2018-11-26", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "192108"} , {"_value" : "192109"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-11-26T17:43:55.157Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-11-16", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Diabetes: Medical Equipment"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what representations he has received from (a) the public and (b) charities on the benefits of making flash glucose monitoring technology available to all patients with diabetes.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4079", "label" : {"_value" : "Biography information for Julian Sturdy"} } , "tablingMemberConstituency" : {"_value" : "York Outer"} , "tablingMemberPrinted" : [{"_value" : "Julian Sturdy"} ], "uin" : "192110"} , {"_about" : "http://data.parliament.uk/resources/43153", "AnsweringBody" : [{"_value" : "Prime Minister"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/43153/answer", "answerText" : {"_value" : "

I did not discuss this issue during my recent visit to Israel.<\/p>

<\/p>

The Government consistently call on Israel to join the Nuclear Non Proliferation Treaty as a non-nuclear weapon state and to agree a full scope Comprehensive Safeguards Agreement with the International Atomic Energy Agency. We continue to support the objective of a Middle East free from Weapons of Mass Destruction and continue to encourage Israel to participate in discussions to that end.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1467", "label" : {"_value" : "Biography information for Lord Cameron of Chipping Norton"} } , "answeringMemberConstituency" : {"_value" : "Witney"} , "answeringMemberPrinted" : {"_value" : "Mr David Cameron"} , "dateOfAnswer" : {"_value" : "2014-03-18", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-03-18T12:00:00.00Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "23"} , "answeringDeptShortName" : {"_value" : ""} , "answeringDeptSortName" : {"_value" : ""} , "date" : {"_value" : "2014-03-13", "_datatype" : "dateTime"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Prime Minister, whether the possibility of Israel (a) disarming its nuclear weapons capability and (b) joining the Nuclear Non-Proliferation Treaty was discussed with (i) his Israeli counterpart, (ii) other Israeli ministers and (iii) members of the Knesset during his visit to Israel on 12 and 13 March 2014.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/545", "label" : {"_value" : "Biography information for Paul Flynn"} } , "tablingMemberConstituency" : {"_value" : "Newport West"} , "tablingMemberPrinted" : [{"_value" : "Paul Flynn"} ], "uin" : "192110"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }